Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Virbac: Availability_Half-yearly financial report_June 2018_Erratum

Posted on: 21 Sep 18
Virbac: Availability of the half-yearly financial report as of June 30, 2018 _ Erratum

Public release - September 21, 2018

The sales breakdown table on page 3 of the half-year financial report published on September 17, 2018 included distribution errors by geographical area.

The corrected table and related comments corrections have been restated in the semi-annual financial report available on the company's website: under the section Investors - Financial reports - 2018.

The company also amended the same corrections on the investors' presentation available on the site.

Virbac: NYSE Euronext - compartment B - ISIN code: FR0000031577/SYMBOL: VIRP
Corporate finance: +33 4 92 08 71 32 - -

Virbac: Availability_Half-yearly financial report_June 2018_Erratum

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Virbac via GlobeNewswire

Last updated on: 22/09/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.